Read the case study and learn how RegASK’s Guidebooks assist CROs in all regulatory aspects of hybrid or decentralized clinical trials.
A global CRO specializing in hybrid and Decentralized Clinical Trials wanted to better guide their clients for clinical study execution and help them improve clinical trial efficiency.
- Developed detailed Guidebooks highlighting all the aspects of the regulatory requirements to implement hybrid or fully decentralized clinical trials in over 10 major markets covering Asia, LATAM, EU and North America
- Produced a country requirement overview for registration of digital clinical studies
The client was able to implement DCTs in 6 countries and is constantly updated on changes with the RegAlert intelligence and monitoring solution.
Need regulatory support on DCTs?
Speak to our experts
Or you can also WhatsApp us by clicking this number +65 8128 2161